argus

Biocon Ltd.

NSE: BIOCONINE376G0101365,391 Cr

Timeline

Time (IST)TypeMEventSrc
12 Jan, 04:47 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Qualified Institutional Placementbse
12 Jan, 04:10 pmBiocon Limited has informed the Exchange about approval of Unaudited Condensed Consolidated Interim Financial Statementsnse
12 Jan, 08:40 amBiocon Limited has informed the Exchange regarding 'Notification to Stock Exchanges '.nse
08 Jan, 01:56 pmBiocon Limited has informed the Exchange about Record Date for Commercial Papernse
06 Jan, 05:36 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
06 Jan, 05:34 pmBiocon Limited has informed the Exchange regarding a press release dated January 06, 2026, titled "Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference.".nse
06 Jan, 09:38 amBiocon Ltd - 532523 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
05 Jan, 10:05 pmBiocon Limited has informed the Exchange about Acquisition of equity shares of Biocon Biologics Limitednse
05 Jan, 10:02 pmBiocon Limited has informed the Exchange regarding allotment of 17,12,79,553 equity shares pursuant to Preferential Issue at its meeting held on January 05, 2026nse
05 Jan, 09:51 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
05 Jan, 09:48 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Allotmentbse
05 Jan, 12:34 pmBiocon Limited has informed the Exchange about early full redemption of NCDs by the Companynse
02 Jan, 04:50 pmBiocon Limited has informed the Exchange about Issue of Commercial Papers of Rs. 200 Croresnse
24 Dec, 08:27 pmBiocon Limited has informed the Exchange about Intimation of Record Date for Commercial Papernse
23 Dec, 05:34 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
23 Dec, 05:34 pmBiocon Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Biocon Limited signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries".nse
23 Dec, 09:11 amBiocon Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement".nse
23 Dec, 09:09 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
22 Dec, 07:37 pmBiocon Limited has informed the Exchange about Issue of Commercial Papersnse
18 Dec, 05:44 pmBiocon Limited has informed the Exchange regarding 'Notification to Stock Exchanges'.nse
17 Dec, 08:14 amBiocon Limited has informed the Exchange regarding a press release dated December 17, 2025, titled "Biocon Biologics Recognized as Asia IP Elite for 2025 by IAM.".nse
17 Dec, 08:09 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
16 Dec, 08:12 pmBiocon Limited has informed the Exchange about Credit Ratingnse
16 Dec, 08:09 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
16 Dec, 07:21 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
16 Dec, 07:18 pmBiocon Limited has informed the Exchange about Credit Ratingnse
15 Dec, 08:33 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
15 Dec, 08:29 amBiocon Limited has informed the Exchange regarding a press release dated December 15, 2025, titled "Biocon Limited launches its Glucagon-like Peptide-1 (GLP -1), Liraglutide, in the Netherlands".nse
13 Dec, 01:42 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
13 Dec, 01:40 pmBiocon Limited has informed the Exchange regarding a press release dated December 13, 2025, titled "Biocon Biologics Signs Settlement and License Agreement to Commercialize Biosimilar Aflibercept Worldwide".nse
11 Dec, 01:22 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
11 Dec, 01:15 pmBiocon Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "S&P Global Places Biocon Biologics on Positive CreditWatchOn Account of Accelerated Debt Reduction".nse
10 Dec, 01:18 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Credit Ratingbse
10 Dec, 01:14 pmBiocon Limited has informed the Exchange about Credit Ratingnse
09 Dec, 08:04 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
09 Dec, 08:01 pmBiocon Limited has informed the Exchange about Investor Presentationnse
06 Dec, 11:30 amBiocon Limited has informed the Exchange about fund raising through issuance of Commercial Papersnse
06 Dec, 11:29 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Raising of Fundsbse
06 Dec, 11:27 amBiocon Limited has informed the Exchange about raising of funds by way of issuance of any instrument or securitynse
06 Dec, 11:24 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Raising of Fundsbse
06 Dec, 11:20 amBiocon Limited has informed the Exchange about issue of Securities on preferential basisnse
06 Dec, 11:18 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Issue of Securitiesbse
06 Dec, 11:00 amBiocon Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.nse
06 Dec, 10:58 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associationbse
06 Dec, 10:55 amBiocon Limited has informed the Exchange about Acquisitionnse
06 Dec, 10:54 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Acquisitionbse
06 Dec, 10:52 amBiocon Limited has informed the Exchange about outcome of Board Meetingnse
06 Dec, 10:47 amBiocon Limited has informed the Exchange about Presentationnse
06 Dec, 10:44 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
06 Dec, 10:17 amBiocon Limited has informed the Exchange regarding a press release dated December 06, 2025, titled "Biocon Limited to Integrate Biocon Biologics Limited to Create a Unified Global Biopharmaceutical Leader".nse